LSV ASSET MANAGEMENT - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 213 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
LSV ASSET MANAGEMENT ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$9,767
-20.0%
212,3680.0%0.02%
-14.8%
Q2 2023$12,205
+880.3%
212,368
+539.7%
0.03%
+800.0%
Q1 2023$1,245
+315.0%
33,200
+210.3%
0.00%
+200.0%
Q4 2022$300
-99.9%
10,7000.0%0.00%0.0%
Q3 2022$301,000
-93.2%
10,700
-91.6%
0.00%
-90.0%
Q2 2022$4,420,000
-11.9%
127,053
-9.1%
0.01%
+11.1%
Q1 2022$5,017,000
+153.9%
139,753
+64.7%
0.01%
+200.0%
Q4 2021$1,976,000
+110.9%
84,846
+72.1%
0.00%
+50.0%
Q3 2021$937,000
+53.1%
49,300
+62.2%
0.00%
+100.0%
Q2 2021$612,00030,4000.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$4,884,3754.79%
SHAKER INVESTMENTS LLC/OH 82,253$3,084,4881.72%
Mesirow Institutional Investment Management, Inc. 325,669$12,212,5881.33%
Portolan Capital Management 340,593$12,772,2381.22%
OBERWEIS ASSET MANAGEMENT INC/ 178,200$6,682,5001.04%
Granite Investment Partners, LLC 536,821$20,130,7880.84%
Capital Impact Advisors, LLC 15,304$573,9000.70%
Hillsdale Investment Management Inc. 155,038$5,813,9260.50%
GLOBEFLEX CAPITAL L P 89,192$3,344,7000.41%
Jackson Creek Investment Advisors LLC 25,877$9700.41%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders